We do not publish a verdict for Akso Health Group ADR (AHG) and EDAP TMS SA ADR (FOCL) is overvalued.
We publish an intrinsic value for FOCL but not for AHG, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: there is no balance sheet on file to value what it owns.
Leak Score 0/100 on 1 of 12 signals
A 1.5x revenue multiple, discounted for its losses, values the shares at $2.24; the price of $4.27 is 91% above that value.
Leak Score 0/100 on 2 of 12 signals
| Metric | AHG | FOCL |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $0.74 | $4.27 |
| Intrinsic value | — | $2.24 |
| Margin of safety | — | -91% |
| Leak Score | 0/100 (1/12) | 0/100 (2/12) |
| Market cap | $632M | $160M |
| Revenue growth, 5 years | 51.1% | 8.3% |
| Operating margin | -28.9% | -39.3% |
| Net margin | -135.1% | -56.3% |
| Return on equity | -9.9% | -263.8% |
| Debt to equity | 0.01 | — |
| P/B | 3.5x | — |